{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:50:38Z","timestamp":1787611838105,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.taap.2025.117701","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:53:20Z","timestamp":1767113600000},"page":"117701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Benign cardiac troponin I release induced by elevated beat rate is associated with membrane bleb formation"],"prefix":"10.1016","volume":"507","author":[{"given":"Jomana","family":"Hatahet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah J.","family":"Nonarath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Zafiratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geena","family":"Jasiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kohnken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Treadway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.taap.2025.117701_bb0005","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcmg.2019.12.020","article-title":"Myocardial injury and compromised cardiomyocyte integrity following a Marathon run","volume":"13","author":"Aengevaeren","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.taap.2025.117701_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.015912","article-title":"Cardiac troponin release after endurance exercise: still much to learn","volume":"9","author":"Airaksinen","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002954","article-title":"Composition of cardiac troponin release differs after marathon running and myocardial infarction","volume":"11","author":"Airaksinen","year":"2024","journal-title":"Open Heart"},{"issue":"16","key":"10.1016\/j.taap.2025.117701_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14165644","article-title":"Paroxysmal supraventricular tachycardia and troponin elevation: insights into mechanisms, risk factors, and outcomes","volume":"14","author":"Aletras","year":"2025","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.taap.2025.117701_bb0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1242\/dmm.016170","article-title":"The zebrafish as a tool to identify novel therapies for human cardiovascular disease","volume":"7","author":"Asnani","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"3","key":"10.1016\/j.taap.2025.117701_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.15420\/ecr.2019.28.2","article-title":"Troponins, acute coronary syndrome and renal disease: from acute kidney injury through end-stage kidney disease","volume":"14","author":"Banerjee","year":"2019","journal-title":"Eur. Cardiol."},{"issue":"6868","key":"10.1016\/j.taap.2025.117701_bb0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.taap.2025.117701_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014408","article-title":"Duration of elevated heart rate is an important predictor of exercise-induced troponin elevation","volume":"9","author":"Bjorkavoll-Bergseth","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0045","article-title":"Advances in the study of heart development and disease using zebrafish","volume":"3","author":"Brown","year":"2016","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/10408363.2016.1261270","article-title":"Biomarkers for monitoring chemotherapy-induced cardiotoxicity","volume":"54","author":"Cao","year":"2017","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"9","key":"10.1016\/j.taap.2025.117701_bb0055","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrm2453","article-title":"Blebs lead the way: how to migrate without lamellipodia","volume":"9","author":"Charras","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.taap.2025.117701_bb0060","article-title":"Elevation mechanisms and diagnostic consideration of cardiac troponins under conditions not associated with myocardial infarction. Part 2","volume":"11","author":"Chaulin","year":"2021","journal-title":"Life (Basel)"},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0022-5223(96)70279-9","article-title":"Effects of myocardial ischemia on the release of cardiac troponin I in isolated rat hearts","volume":"112","author":"Chocron","year":"1996","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"10","key":"10.1016\/j.taap.2025.117701_bb0070","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1021\/acs.jmedchem.3c02412","article-title":"Cardiac troponin activator CK-963 increases cardiac contractility in rats","volume":"67","author":"Collibee","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.taap.2025.117701_bb0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2015.03.008","article-title":"Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types","volume":"285","author":"Doherty","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117701_bb0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsams.2013.12.002","article-title":"Predictors of cardiac troponin release after a marathon","volume":"18","author":"Eijsvogels","year":"2015","journal-title":"J. Sci. Med. Sport"},{"issue":"16","key":"10.1016\/j.taap.2025.117701_bb0085","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/01.CIR.103.16.2035","article-title":"Preload induces troponin I degradation independently of myocardial ischemia","volume":"103","author":"Feng","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004040","article-title":"Myocardial injury in patients with Sepsis and its association with Long-term outcome","volume":"11","author":"Frencken","year":"2018","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.taap.2025.117701_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.rvsc.2016.02.001","article-title":"Prospective evaluation of Doppler echocardiography, tissue Doppler imaging and biomarkers measurement for the detection of doxorubicin-induced cardiotoxicity in dogs: a pilot study","volume":"105","author":"Gallay-Lepoutre","year":"2016","journal-title":"Res. Vet. Sci."},{"issue":"11 Pt 1","key":"10.1016\/j.taap.2025.117701_bb0100","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1540-8159.1990.tb04014.x","article-title":"Effects of increasing heart rate induced by efferent sympathetic neuronal stimulation, isoproterenol or cardiac pacing on myocardial function and oxygen utilization","volume":"13","author":"Gardner","year":"1990","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.taap.2015.07.024","article-title":"High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays","volume":"288","author":"Gilchrist","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2025.117701_bb0110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ijcard.2016.06.243","article-title":"Troponin and exercise","volume":"221","author":"Gresslien","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.taap.2025.117701_bb0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfm026","article-title":"Preclinical cardiovascular risk assessment in modern drug development","volume":"97","author":"Guth","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jvim.15414","article-title":"Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin","volume":"33","author":"Hallman","year":"2019","journal-title":"J. Vet. Intern. Med."},{"issue":"4","key":"10.1016\/j.taap.2025.117701_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00126839-200708040-00002","article-title":"Preclinical cardiac safety assessment of drugs","volume":"8","author":"Hanton","year":"2007","journal-title":"Drugs R D"},{"issue":"6","key":"10.1016\/j.taap.2025.117701_bb0130","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00424-007-0354-8","article-title":"Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation","volume":"455","author":"Hessel","year":"2008","journal-title":"Pflugers Arch."},{"issue":"5\u20136","key":"10.1016\/j.taap.2025.117701_bb0135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cca.2009.12.009","article-title":"Cardiac troponin may be released by ischemia alone, without necrosis","volume":"411","author":"Hickman","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.taap.2025.117701_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000668","article-title":"Long-term cardiovascular risks associated with an elevated heart rate: the Framingham heart study","volume":"3","author":"Ho","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.taap.2025.117701_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/gbe\/evac173","article-title":"A revised perspective on the evolution of troponin I and troponin T gene families in vertebrates","volume":"15","author":"Joyce","year":"2023","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.taap.2025.117701_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2015.12.002","article-title":"CSAHi study: evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia - effects of 7 reference compounds at 10 facilities","volume":"78","author":"Kitaguchi","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.taap.2025.117701_bb0155","article-title":"Generation of cardiomyocytes by atrioventricular node cells in long-term cultures","volume":"26","author":"Kiuchi","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"issue":"3","key":"10.1016\/j.taap.2025.117701_bb0160","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1249\/01.MSS.0000053736.51903.0E","article-title":"Exercise-induced increases in cardiac troponins and prothrombotic markers","volume":"35","author":"Koller","year":"2003","journal-title":"Med. Sci. Sports Exerc."},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/14740338.2012.639358","article-title":"Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models","volume":"11","author":"Kraushaar","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"issue":"11","key":"10.1016\/j.taap.2025.117701_bb0170","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.CIR.102.11.1221","article-title":"Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction","volume":"102","author":"Labugger","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijcard.2003.10.062","article-title":"Cardiac troponin I release in non-ischemic reversible myocardial injury from acute diphtheric myocarditis","volume":"98","author":"Lakkireddy","year":"2005","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.taap.2025.117701_bb0180","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11897-023-00620-2","article-title":"Differentiating cardiac troponin levels during cardiac myosin inhibition or cardiac myosin activation treatments: drug effect or the canary in the coal mine?","volume":"20","author":"Lee","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.taap.2025.117701_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.taap.2016.01.015","article-title":"Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes","volume":"296","author":"Lee","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.taap.2025.117701_bb0190","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ajem.2019.12.007","article-title":"An emergency medicine approach to troponin elevation due to causes other than occlusion myocardial infarction","volume":"38","author":"Long","year":"2020","journal-title":"Am. J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.taap.2025.117701_bb0195","first-page":"553","article-title":"How is cardiac troponin released from injured myocardium?","volume":"7","author":"Mair","year":"2018","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.yrtph.2014.07.014","article-title":"Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development","volume":"70","author":"Mangipudy","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117701_bb0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.119.041874","article-title":"Effect of exercise intensity and duration on cardiac troponin release","volume":"141","author":"Marshall","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.taap.2025.117701_bb0210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/CCM.0000000000001473","article-title":"Sequential N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin measurements during albumin replacement in patients with severe Sepsis or septic shock","volume":"44","author":"Masson","year":"2016","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.taap.2025.117701_bb0215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0031-1301322","article-title":"Post-exercise cardiac troponin release is related to exercise training history","volume":"33","author":"Mehta","year":"2012","journal-title":"Int. J. Sports Med."},{"issue":"5","key":"10.1016\/j.taap.2025.117701_bb0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00007256-200838050-00005","article-title":"Cardiac troponin T release after prolonged strenuous exercise","volume":"38","author":"Michielsen","year":"2008","journal-title":"Sports Med."},{"issue":"11 Suppl 1","key":"10.1016\/j.taap.2025.117701_bb0225","first-page":"S3","article-title":"Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays","volume":"128","author":"Navarrete","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.taap.2025.117701_bb0230","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/SHK.0000000000000811","article-title":"Cardiac troponin release is associated with biomarkers of inflammation and ventricular dilatation during critical illness","volume":"47","author":"Ostermann","year":"2017","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.taap.2025.117701_bb0235","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.metabol.2012.09.012","article-title":"Increased circulating high-sensitivity troponin T concentrations in children and adolescents with obesity and the metabolic syndrome: a marker for early cardiac damage?","volume":"62","author":"Pervanidou","year":"2013","journal-title":"Metabolism"},{"issue":"34","key":"10.1016\/j.taap.2025.117701_bb0240","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.2174\/1381612825666181120155953","article-title":"The role of calcium handling mechanisms in reperfusion injury","volume":"24","author":"Pittas","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.taap.2025.117701_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14072226","article-title":"Impact of high intensity contact physical activity during a match on echocardiographic parameters and high-sensitivity troponin I in competitive Rugby players","volume":"14","author":"Radic","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.taap.2025.117701_bb0250","first-page":"6","article-title":"Levels of troponin release can aid in the early exclusion of stress-induced (takotsubo) cardiomyopathy","volume":"14","author":"Ramaraj","year":"2009","journal-title":"Exp. Clin. Cardiol."},{"issue":"10","key":"10.1016\/j.taap.2025.117701_bb0255","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1021\/acs.jmedchem.3c02413","article-title":"Discovery of Nelutroctiv (CK-136), a selective cardiac troponin activator for the treatment of cardiovascular diseases associated with reduced cardiac contractility","volume":"67","author":"Romero","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2025.117701_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.926394","article-title":"Blebs-formation, regulation, positioning, and role in amoeboid cell migration","volume":"10","author":"Schick","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.taap.2025.117701_bb0265","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.78.6.3363","article-title":"Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells","volume":"78","author":"Seamon","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.taap.2025.117701_bb0270","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1038\/s41596-018-0076-8","article-title":"Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity","volume":"13","author":"Sharma","year":"2018","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.taap.2025.117701_bb0275","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1249\/mss.0b013e318153ff78","article-title":"Exercise-induced cardiac troponin T release: a meta-analysis","volume":"39","author":"Shave","year":"2007","journal-title":"Med. Sci. Sports Exerc."},{"issue":"3","key":"10.1016\/j.taap.2025.117701_bb0280","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jacc.2010.03.037","article-title":"Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications","volume":"56","author":"Shave","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.taap.2025.117701_bb0285","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00726-018-2578-7","article-title":"Zebrafish heart failure models: opportunities and challenges","volume":"50","author":"Shi","year":"2018","journal-title":"Amino Acids"},{"issue":"3","key":"10.1016\/j.taap.2025.117701_bb0290","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.taap.2013.09.017","article-title":"Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity","volume":"273","author":"Sirenko","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117701_bb0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/0886022X.2011.623440","article-title":"Troponins in acute kidney injury","volume":"34","author":"Song","year":"2012","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0300","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1373\/clinchem.2016.261511","article-title":"Identification and characterization of cardiac troponin T fragments in serum of patients suffering from acute myocardial infarction","volume":"63","author":"Streng","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.taap.2025.117701_bb0305","series-title":"Target Heart Rates Chart","year":"2024"},{"issue":"44","key":"10.1016\/j.taap.2025.117701_bb0310","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.0903353106","article-title":"Role of cortical tension in bleb growth","volume":"106","author":"Tinevez","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.taap.2025.117701_bb0315","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.taap.2025.117701_bb0320","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1373\/jalm.2018.027144","article-title":"Cardiac troponin T: only small molecules in recreational runners after Marathon completion","volume":"3","author":"Vroemen","year":"2019","journal-title":"J. Appl. Lab. Med."},{"issue":"3","key":"10.1016\/j.taap.2025.117701_bb0325","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1472-8206.2002.00099.x","article-title":"The application of in vitro methods to safety pharmacology","volume":"16","author":"Wakefield","year":"2002","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2025.117701_bb0330","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacbts.2017.01.006","article-title":"Brief myocardial ischemia produces cardiac troponin I release and focal myocyte apoptosis in the absence of pathological infarction in swine","volume":"2","author":"Weil","year":"2017","journal-title":"JACC Basic. Transl. Sci."},{"key":"10.1016\/j.taap.2025.117701_bb0335","series-title":"A Guide for the Laboratory Use of Zebrafish (Danio rerio)","author":"Westerfield","year":"2000"},{"issue":"24","key":"10.1016\/j.taap.2025.117701_bb0340","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.jacc.2011.01.029","article-title":"Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?","volume":"57","author":"White","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.taap.2025.117701_bb0345","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.flm.2017.09.003","article-title":"Release of cardiac troponin from healthy and damaged myocardium","volume":"1","author":"Wu","year":"2017","journal-title":"Front. Lab. Med."},{"issue":"10","key":"10.1016\/j.taap.2025.117701_bb0350","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1248\/bpb.34.1523","article-title":"Electrocardiographic and biochemical evidence for the Cardioprotective effect of antioxidants in acute doxorubicin-induced cardiotoxicity in the beagle dogs","volume":"34","author":"Xin","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.taap.2025.117701_bb0355","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13287-017-0473-x","article-title":"Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes","volume":"8","author":"Zhao","year":"2017","journal-title":"Stem Cell Res. Ther."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:36:29Z","timestamp":1769103389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25004776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":71,"alternative-id":["S0041008X25004776"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117701","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benign cardiac troponin I release induced by elevated beat rate is associated with membrane bleb formation","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117701"}}